Invention Grant
- Patent Title: Recombinant clusterin and use thereof in the treatment and prevention of disease
-
Application No.: US14957030Application Date: 2015-12-02
-
Publication No.: US10464994B2Publication Date: 2019-11-05
- Inventor: Yong-Jian Geng
- Applicant: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: C07K14/775
- IPC: C07K14/775 ; A61K38/00 ; A61K9/00 ; A61K9/19
Abstract:
Recombinant clusterin polypeptides and compositions comprising the same are provided. In some aspects, recombinant clusterin or nucleic acids encoding the same may be used for treating and preventing an abnormality of morphology and function in a mammal with disease (e.g., cardiovascular diseases or alcoholism).
Public/Granted literature
- US20160222088A1 RECOMBINANT CLUSTERIN AND USE THEREOF IN THE TREATMENT AND PREVENTION OF DISEASE Public/Granted day:2016-08-04
Information query
